Abstract
Eosinophilic bronchitis without asthma can cause a persistent non-productive cough which is resistant to bronchodilator therapy. To understand the mechanism of the cough in this disorder, an animal model of eosinophilic bronchitis was developed. Guinea-pigs were treated with transnasal administration of polymyxin B or saline twice a week for 3 weeks. The number of eosinophils in bronchoalveolar lavage fluid increased in polymyxin B-treated animals when compared with those treated with saline. In addition, histological examination showed that the number of eosinophils infiltrated into the tracheal epithelium increased; injury to the tracheal epithelium was greater in polymyxin B-treated animals. The numbers of coughs induced by saline and each concentration of capsaicin (10−18, 10−16, 10−14M) were greater in the polymyxin B-treated animals. FK-224 (a neurokinin receptor antagonist) decreased the heightened cough reflex in this animal model of eosinophilic bronchitis. These findings suggest that neuropeptides, and particularly neurokinins, are involved in the heightened cough receptor sensitivity in eosinophilic bronchitis without asthma. This has implications for better understanding of this disorder and its treatment.
Similar content being viewed by others
References
McFadden ER Jr. Exertional dyspnea and cough as preludes to acute attacks of bronchial asthma.N Engl J Med 1975;292: 555–559.
Fujimura M, Sakamoto S, Tamotsu M. Bronchodilator-resistive cough in atopic patients: bronchial reversibility and hyperresponsiveness.Intern Med 1992;31: 447–452.
Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma.Lancet 1989;17: 1346–1348.
Ogawa H, Fujimura M, Matsuda T, Nakamura H, Kumabashiri I, Kitagawa S. Transient wheeze: eosinophilic broncho-bronchiolitis in acute eosinophilic pneumonia.Chest 1992;104: 493–496.
Pincus SH. Production of eosinophil-rich guinea pig peritoneal exudates.Blood 1978;52: 127–134.
Davis WB, Husney RM, Mohammed BS, Pawluk LJ, Ackerman GA, Sagone AL. Activation and deactivation of guinea pig peritoneal eosinophils during chronic polymyxin B stimulation.J Leuko Biol 1989;45: 147–154.
Sun X, Davis WB, Fukuda Y, Ferrans VJ, Crystal RG. Experimental polymyxin B-induced interstitial lung disease characterized by an accumulation of cytotoxic eosinophils in the alveolar structures.Am Rev Respir Dis 1985;131: 103–108.
Laycock SM, Smith H, Spicer BA. Airway hyperreactivity and blood, lung and airway eosinophilia in rats treated with Sephadex particles.Int Arch Allergy Appl Immunol 1986;81: 363–367.
Nogami M, Suko M, Okudaira H, Miyamoto T, Shiga J, Ito M, Kasuya S. Experimental pulmonary eosinophilia in mice by ascaris suum extract.Am Rev Respir Dis 1990;141: 1289–1295.
Gleich GL, Loegering D. Selective stimulation and purification of eosinophils and nentrophils from guinea pig peritoneal fluids.J Clin Med 1973;85: 522–526.
Kohrogi H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh R, Patton JS, Borson DB. Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs.J Clin Invest 1989;84: 781–786.
Jones T, Masson P, Hamel R, Bruunet G, Holme G, Girard Y, Larue M, Rokach J. Biological activity of leukotriene sulfones on respiratory tissues.Prostaglandins 1982;24: 279.
Fujimura M. Inhibitory effects of steroids on slow-reacting substance of anaphylaxis (SRS-A) mediated bronchoconstriction in the guinea pigin vivo.Jpn J Allergol 1983;32: 365–375.
Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in adult: the spectrum and frequency of causes and successful outcome of specific therapy.Am Rev Respir Dis 1981;123: 413–417.
Nishi K, Fujimura M, Myou S, Ooka T, Matsuda T. The importance of eosinophilic inflammation of the airways in chronic nonproductive cough without asthma (abstract).Jpn J Allergol 1992;41: 302.
Widdicombe JG. Receptors in the trachea and bronchi of the cat.J Physiol 1954;123: 71–104.
Coleridge HM, Coleridge JCG, Ginzel KH, Baker DG, Banzett RB, Morrison MA. Stimulation of ‘irritant’ receptors and afferent C-fibres in the lungs by prostaglandins.Nature 1976;264: 451–453.
Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory disease.TIPS 1990;111: 185–189.
Barnes PJ. Asthma as an axon reflex.Lancet 1986; i: 242–245.
Jancsó N., Jancsó-Gábor A, Szolcsányi J. Direct evidence for neurogenic inflammation and its preventation by denervation and by pretreatment with capsaicin.Br J Pharmac Chemother 1967;31: 138–151.
Morimoto H, Murai M, Maeda Y, Yamaoka M, Nishikawa M, Kiyotoh Sumio, Fujii T. FK-224, a novel cyclopeptide substance P antagonist with NK, and NK2 receptor selectivity.J Pharmacol Exp Ther 1992;262: 398–402.
Murai M, Morlmoto H, Maeda Y, Yamaoka M, Kiyotoh S, Nishikawa M, Fujii T. Effects of FK-224, a novel compound NK, and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs.
Dusser DJ, Umeno E, Graf PD, Djokic T, Borson DB, Nedel JA. Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstrictionin vivo.J Appl Physiol 1988;65: 2585–2591.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ogawa, H., Fujimura, M., Saito, M. et al. The effect of the neurokinin antagonist FK-224 on the cough response to inhaled capsaicin in a new model of guinea-pig eosinophilic bronchitis induced by intranasal polymyxin B. Clinical Autonomic Research 4, 19–28 (1994). https://doi.org/10.1007/BF01828834
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01828834